Showing results (361-370 of 510) with videos related to
Sort By:
Pageof 51
Neurobiology of Disease|July 21, 2004
Hypothalamic activation after stimulation of the superior sagittal sinus in the cat: a Fos studyLaura Benjamin, Miles J Levy, Michele P Lasalandra, et al.Brain : a Journal of Neurology|August 19, 2020
Differential medication overuse risk of novel anti-migraine therapeuticsChonlawan Saengjaroentham, Lauren C Strother, Isaac Dripps, et al.Cephalalgia : an International Journal of Headache|April 16, 2019
Efficacy and safety of erenumab (AMG334) in episodic migraine patients with prior preventive treatment failure: A subgroup analysis of a randomized, double-blind, placebo-controlled studyPeter J Goadsby, Koen Paemeleire, Gregor Broessner, et al.The New England Journal of Medicine|March 12, 2004
Calcitonin gene-related peptide receptor antagonist BIBN 4096 BS for the acute treatment of migraineJes Olesen, Hans-Christoph Diener, Ingo W Husstedt, et al.Cephalalgia : an International Journal of Headache|February 21, 2025
Efficacy of ubrogepant and atogepant in males and females with migraine: A secondary analysis of randomized clinical trialsPeter J Goadsby, Tim P Jürgens, Elimor Brand-Schieber, et al.Headache|March 22, 2021
Efficacy of ubrogepant based on prior exposure and response to triptans: A post hoc analysisAndrew M Blumenfeld, Peter J Goadsby, David W Dodick, et al.Cephalalgia : an International Journal of Headache|September 7, 2011
Immunohistochemical characterization of calcitonin gene-related peptide in the trigeminal system of the familial hemiplegic migraine 1 knock-in mouseRammya Mathew, Anna P Andreou, Linda Chami, et al.Journal of Animal Science|August 16, 2006
Meal size and feeding frequency influence serum leptin concentration in yearling horsesS M Steelman, E M Michael-Eller, P G Gibbs, et al.Headache|July 20, 2018
Identifying Natural Subgroups of Migraine Based on Comorbidity and Concomitant Condition Profiles: Results of the Chronic Migraine Epidemiology and Outcomes (CaMEO) StudyRichard B Lipton, Kristina M Fanning, Dawn C Buse, et al.The Lancet. Neurology|February 21, 2023
Safety, tolerability, and efficacy of zavegepant 10 mg nasal spray for the acute treatment of migraine in the USA: a phase 3, double-blind, randomised, placebo-controlled multicentre trialRichard B Lipton, Robert Croop, David A Stock, et al.Pageof 51